JP2023533289A5 - - Google Patents
Info
- Publication number
- JP2023533289A5 JP2023533289A5 JP2023501090A JP2023501090A JP2023533289A5 JP 2023533289 A5 JP2023533289 A5 JP 2023533289A5 JP 2023501090 A JP2023501090 A JP 2023501090A JP 2023501090 A JP2023501090 A JP 2023501090A JP 2023533289 A5 JP2023533289 A5 JP 2023533289A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- thc
- acceptable salt
- carbonic anhydrase
- anhydrase inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020902368 | 2020-07-09 | ||
| AU2020902368A AU2020902368A0 (en) | 2020-07-09 | A method of treatment | |
| PCT/AU2021/050734 WO2022006636A1 (en) | 2020-07-09 | 2021-07-09 | Compositions and methods for the treatment of obstructive sleep apnoea (osa) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023533289A JP2023533289A (ja) | 2023-08-02 |
| JP2023533289A5 true JP2023533289A5 (enExample) | 2024-07-09 |
| JP7796718B2 JP7796718B2 (ja) | 2026-01-09 |
Family
ID=79553355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501090A Active JP7796718B2 (ja) | 2020-07-09 | 2021-07-09 | 閉塞性睡眠時無呼吸（ｏｓａ）の治療のための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230310364A1 (enExample) |
| EP (1) | EP4178568A4 (enExample) |
| JP (1) | JP7796718B2 (enExample) |
| AU (1) | AU2021306424A1 (enExample) |
| CA (1) | CA3182528A1 (enExample) |
| CO (1) | CO2023000118A2 (enExample) |
| IL (1) | IL299212A (enExample) |
| WO (1) | WO2022006636A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023289652A1 (en) * | 2022-06-21 | 2024-12-12 | Apnimed, Inc. (Delaware) | Methods of treating sleep apnea with a combination of a cannabinoid and a carbonic anhydrase inhibitor |
| AU2023404665A1 (en) * | 2022-11-29 | 2025-07-17 | Incannex Healthcare Limited | A method of treating obstructive sleep apnoea (osa) |
| WO2025107039A1 (en) * | 2023-11-23 | 2025-05-30 | Incannex Healthcare Limited | Composition comprising tetrahydrocannabinol and acetazolamide in a fixed dose combination capsule |
| WO2025191322A1 (en) * | 2024-03-11 | 2025-09-18 | Mousavi Mirzaei Seyed Mohammad | Therapeutic composition for improving symptoms of obstructive sleep apnea |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5714910B2 (ja) * | 2008-01-09 | 2015-05-07 | チャールストン ラボラトリーズ，インコーポレイテッド | 薬学的組成物 |
| WO2019071302A1 (en) * | 2017-10-09 | 2019-04-18 | The University Of Sydney | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING EPILEPSY CRISES |
| EP3746068A4 (en) * | 2018-01-29 | 2021-11-03 | Evero | COMPOSITIONS AND METHODS OF TREATMENT FOR OBSTRUCTIVE SLEEP APNEA |
| WO2019180706A1 (en) * | 2018-03-19 | 2019-09-26 | Bol Pharma Ltd. | Methods and compositions for treating epilepsy and associated disorders |
| CN117177741A (zh) * | 2021-04-16 | 2023-12-05 | 爱普宁公司(特拉华) | 用于治疗睡眠呼吸暂停的去甲肾上腺素再摄取抑制剂和大麻素的组合 |
-
2021
- 2021-07-09 CA CA3182528A patent/CA3182528A1/en active Pending
- 2021-07-09 JP JP2023501090A patent/JP7796718B2/ja active Active
- 2021-07-09 EP EP21837113.6A patent/EP4178568A4/en active Pending
- 2021-07-09 US US18/000,880 patent/US20230310364A1/en active Pending
- 2021-07-09 WO PCT/AU2021/050734 patent/WO2022006636A1/en not_active Ceased
- 2021-07-09 AU AU2021306424A patent/AU2021306424A1/en active Pending
- 2021-07-09 IL IL299212A patent/IL299212A/en unknown
-
2023
- 2023-01-06 CO CONC2023/0000118A patent/CO2023000118A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022058688A5 (enExample) | ||
| JP2013521304A5 (enExample) | ||
| JP2023076465A5 (enExample) | ||
| AU4944799A (en) | A pharmaceutical combination comprising a cox-2 inhibitor and a inos inhibitor | |
| SI2760821T1 (en) | A salt salt of an anti-inflammatory substituted cyclobutenedione compound | |
| RU2012142811A (ru) | Фармацевтические композиции и пероральные дозированные формы пролекарства леводопы и способы применения | |
| JP2012512164A5 (enExample) | ||
| JP2006528699A5 (enExample) | ||
| EA201000120A1 (ru) | Фармацевтические композиции, содержащие холиновые соли янтарной кислоты, для интраназального введения | |
| JP2015510916A5 (enExample) | ||
| JP2021505526A5 (enExample) | ||
| JP2002501039A5 (enExample) | ||
| JP2011512394A5 (enExample) | ||
| JP2023549849A5 (enExample) | ||
| US20170319519A1 (en) | Combination for the treatment of conditions involving muscular pain | |
| WO2019178516A1 (en) | Methods and compositions to treat enteropathic arthritis | |
| JP2023506196A (ja) | 化合物及びα１－アンチトリプシン欠損症の治療のためのそれらの使用 | |
| JP2005519936A5 (enExample) | ||
| US20180125792A1 (en) | Non-steroidal anti-inflammatory drugs for cough | |
| JP2008088189A5 (enExample) | ||
| JP2013518061A5 (enExample) | ||
| MX2025007158A (es) | Inhibidores de gmp?amp sintasa ciclica y sus usos | |
| JP2023527358A5 (enExample) | ||
| CN107898803A (zh) | 虫草素在制备降尿酸药物中的应用 | |
| JPH10507445A (ja) | 神経変性障害の治療におけるシクロオキシゲナーゼ阻害剤の使用 |